An open offer for J.B. Chemicals & Pharmaceuticals has commenced, as announced on November 17, 2025. This offer aims to acquire up to 4,17,45,264 fully paid-up equity shares, representing 26.00% of the company’s expanded share capital. The offer price is set at INR 1,639.18 per share, totaling INR 6,842.8 crore, assuming full acceptance. The original Detailed Public Statement (DPS) was published on July 4, 2025.
Open Offer Launch
The open offer for acquiring shares of J.B. Chemicals & Pharmaceuticals Limited has been officially launched. The announcement was made on November 17, 2025, detailing the terms and conditions of the offer to the eligible shareholders.
Key Offer Details
The open offer is for the acquisition of up to 4,17,45,264 fully paid-up equity shares of J.B. Chemicals & Pharmaceuticals Limited. This represents 26.00% of the expanded share capital of the company.
The offer price has been set at INR 1,639.18 per share. The total outlay for the acquisition, assuming full acceptance, is INR 6,842.8 crore.
Background and Timelines
The original Detailed Public Statement (DPS) related to this open offer was initially published on July 4, 2025. This announcement serves as a corrigendum to the DPS, providing updated information.
Contact Information
For any clarifications or additional information regarding the offer, investors can reach out to:
- Dhruv Bhatia, Managing Director: +91 22 6246 6000, [email protected]
- Kashish Gupta, Vice President: +91 22 6246 6000, [email protected]
Source: BSE
